Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma : the importance of individualized treatment planning and monitoring. / Zornhagen, Kamilla Westarp; Clausen, Malene Martini; Hansen, Anders E.; Law, Ian; McEvoy, Fintan; Engelholm, Svend Aage; Kjær, Andreas; Kristensen, Annemarie Thuri.

I: Diagnostics, Bind 5, Nr. 3, 11.09.2015, s. 372-382.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Zornhagen, KW, Clausen, MM, Hansen, AE, Law, I, McEvoy, F, Engelholm, SA, Kjær, A & Kristensen, AT 2015, 'Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring', Diagnostics, bind 5, nr. 3, s. 372-382. https://doi.org/10.3390/diagnostics5030372

APA

Zornhagen, K. W., Clausen, M. M., Hansen, A. E., Law, I., McEvoy, F., Engelholm, S. A., Kjær, A., & Kristensen, A. T. (2015). Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring. Diagnostics, 5(3), 372-382. https://doi.org/10.3390/diagnostics5030372

Vancouver

Zornhagen KW, Clausen MM, Hansen AE, Law I, McEvoy F, Engelholm SA o.a. Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring. Diagnostics. 2015 sep. 11;5(3):372-382. https://doi.org/10.3390/diagnostics5030372

Author

Zornhagen, Kamilla Westarp ; Clausen, Malene Martini ; Hansen, Anders E. ; Law, Ian ; McEvoy, Fintan ; Engelholm, Svend Aage ; Kjær, Andreas ; Kristensen, Annemarie Thuri. / Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma : the importance of individualized treatment planning and monitoring. I: Diagnostics. 2015 ; Bind 5, Nr. 3. s. 372-382.

Bibtex

@article{8782506ea22d469d932a7ef24869793e,
title = "Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring",
author = "Zornhagen, {Kamilla Westarp} and Clausen, {Malene Martini} and Hansen, {Anders E.} and Ian Law and Fintan McEvoy and Engelholm, {Svend Aage} and Andreas Kj{\ae}r and Kristensen, {Annemarie Thuri}",
year = "2015",
month = sep,
day = "11",
doi = "10.3390/diagnostics5030372",
language = "English",
volume = "5",
pages = "372--382",
journal = "Diagnostics",
issn = "2075-4418",
publisher = "MDPI AG",
number = "3",

}

RIS

TY - JOUR

T1 - Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma

T2 - the importance of individualized treatment planning and monitoring

AU - Zornhagen, Kamilla Westarp

AU - Clausen, Malene Martini

AU - Hansen, Anders E.

AU - Law, Ian

AU - McEvoy, Fintan

AU - Engelholm, Svend Aage

AU - Kjær, Andreas

AU - Kristensen, Annemarie Thuri

PY - 2015/9/11

Y1 - 2015/9/11

U2 - 10.3390/diagnostics5030372

DO - 10.3390/diagnostics5030372

M3 - Journal article

C2 - 26854160

VL - 5

SP - 372

EP - 382

JO - Diagnostics

JF - Diagnostics

SN - 2075-4418

IS - 3

ER -

ID: 151377138